RSS
|
Login
|
Register
HOME
SPECIALTY
Hematology-Oncology
Nurse Practitioners
OB/GYN
Pharmacists
Physician Assistants
Primary Care Physicians
Urologists
THERAPEUTIC CATEGORIES
BRAND
GENERIC
COMPARE
NEWS
Drug News
Drugs in the Pipeline
Drug Safety Alerts and Recalls
New Drug Products
Polls & Surveys
Newsletters
News from Haymarket Journals
RESOURCES
Alerts (Sponsored)
Clinical Charts
Common Medical Abbreviations
Company
Drug Monograph Format
FDA Orange Book
Pharmacology Notes
Professional Associations
Video
Blogs
MPR Publications
Customer Service
Online Banner Ad Specs
Subscribe
DOWNLOAD
CME
JOBS
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Home
>
News
> Polls & Surveys
Current Poll
Recent Polls
DOWNLOAD NOW
Download the MPR Mobile & Desktop Edition for free access to over 4,000 up-to-date, concise drug monographs on your computer or mobile device.
Weekly News Brief
Sign up
for MPR's Weekly News Brief, available free to all visitors! Offerings include drug news and updates, new products, updated clinical charts, and more...
Take Our Survey
Tell us what you think & take our
survey
!
Most Popular
Most Emailed
Most Recent
Antiemetic Medications
Catch-Up Immunization Schedule for Children
Xiaflex approved for Dupuytren's contracture
Oleptro approved for major depressive disorder (MDD)
Juvéderm XC dermal filler approved
Restylane-L and Perlane-L dermal fillers approved
Kalbitor available for hereditary angioedema (HAE)
PreNexa prenatal vitamins reformulated
Tysabri labeling to include safety information on risk of progressive multifocal leukoencephalopathy
Phase 3 study of edoxaban for recurrent venous thromboembolic (VTE)
Antibiotic Formulations
Recommended Immunization Schedule for Ages 0 to 18 Years
Mood Disorder Treatments
McNeil Consumer Healthcare recalls certain over-the-counter (OTC) products
Allergic Conjunctivitis
Antiemetic Medications
Catch-Up Immunization Schedule for Children
Phase 3 study of fidaxomicin for clostridium difficile infection (CDI)
Xiaflex approved for Dupuytren's contracture
FDA warns of counterfeit Alli for weight loss
Orphan drug designation granted for aerosolized alpha1-proteinease inhibitor for alpha1-antitrypsin deficiency
Phase 2 study of tesetaxel for advanced melanoma
Feraheme safety update
Tysabri labeling to include safety information on risk of progressive multifocal leukoencephalopathy
Phase 3 study of fidaxomicin for clostridium difficile infection (CDI)
Antiemetic Medications
NDA submitted for Luveniq for noninfectious uveitis
Oleptro approved for major depressive disorder (MDD)
Xiaflex approved for Dupuytren's contracture
Restylane-L and Perlane-L dermal fillers approved
Sponsored Links